07608692 is referenced by 12 patents and cites 49 patents.

Modified exendins and exendin agonists having an exendin or exendin agonist linked to one or more polyethylene glycol polymers, for example, and related formulations and dosages and methods of administration thereof are provided. These modified exendins and exendin agonists, compositions and methods are useful in treating diabetes and conditions that would be benefited by lowering plasma glucose or delaying and/or slowing gastric emptying or inhibiting food intake.

Title
Exendins and exendin agonists modified with albumin
Application Number
12/101689
Publication Number
7608692 (B2)
Application Date
April 11, 2008
Publication Date
October 27, 2009
Inventor
Andrew A Young
Rancho Santa Fe
CA, US
Kathryn S Prickett
San Diego
CA, US
Agent
Connolly Bove Lodge & Hutz
Assignee
Amylin Pharmaceuticals
CA, US
IPC
A61K 38/00
A61K 38/28
A61K 38/38
View Original Source